Ativa logo — Decoding Blood, Changing Care.

Ativa

Decoding Blood, Changing Care.

Founded 2008 United States St. Paul, United States 20 employees Series Unknown Total: $36.23M Biotechnology, Health Care

General Information

Company Name Ativa
Founded Year 2008
Location United States St. Paul, United States +1
Founders / Decision Makers
Team member
Employees 20
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Ativa moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ativa

Ativa is a biotechnology and health care startup that aims to revolutionize diagnostic testing with their groundbreaking technology. Founded in 2008 and based in the United States, Ativa's slogan "Decoding Blood, Changing Care" encapsulates their mission to make diagnostic test results available in moments, rather than hours and days. Ativa's innovative system enables nurses and assistants to conduct major critical blood and urine tests on-site, by utilizing a card reader as thin as just a few hairs. This eliminates the need for time-consuming and costly "send outs" to other labs, as it only requires a mere drop of blood. Moreover, while there are existing point-of-care tests in the market, Ativa's product stands out for its capability to conduct all the major tests on-site. With more than 200 patents and a universal operating system, Ativa's technology replicates the most important diagnostic lab tests right at the point of care. Notably, the company received a significant $9.50M Venture Round investment on 07 July 2017. The absence of specific information about the investors indicates the possibility of a confidential or undisclosed investment, reflecting the potential interest and confidence in Ativa's disruptive approach to diagnostic testing. With its impactful technology and promising investments, Ativa is well-positioned to make a substantial impact in the biotechnology and healthcare industries.

Taxonomy: Diagnostics, Point of Care, Microfluidics, Hematology, Medical Technology, Healthcare Innovation, Diagnostic Testing, Medical Device Manufacturing, Innovation, Blood Testing, Biomedical Engineering

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 07 Jul 2017
Debt Financing •••••• - 17 Sep 2015
Series B •••••• 7
Investor Investor Investor
•••• ••••
17 Sep 2015
Debt Financing •••••• - 22 May 2013
Series A •••••• - 26 Jul 2012

View All 6 Funding Rounds

Ativa Alternatives & Competitors

Ativa vs
Haemokinesis
Haemokinesis Australia

When every second counts.

34 employees
Biotechnology, Health Care
Ativa vs

Developing point of care testing solutions that empower patients

15 employees
Biotechnology, Health Care
Ativa vs

Commitment to Quality and Care

82 employees
Biotechnology, Hardware

FAQ About Ativa

Decoding Blood, Changing Care.
Ativa was founded in 2008.
Ativa is headquartered in St. Paul, United States.
Ativa operates in the following industries: Biotechnology, Health Care.
Ativa has approximately 20 employees.
Ativa has completed 6 funding rounds, raising a total of $36.23M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Ativa include Haemokinesis, In Vitro Diagnostic Solutions (IVDS), Premier Medical Corporation Private Limited, International Point of Care Inc. | Fortis Life Sciences, PH DIAGNOSTICS LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ativa and Haemokinesis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ativa and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy